EUVIMED · CrossrefJournal
Advanced Cancer Research
ISSN 3106-0382 · ELS Publishing Co. Limited
Latest articles
An update on post-translational modifications of p53 from molecular mechanisms to therapeutic opportunities in cancer
Identification PDF as a biomarker of “cold” CRC using integrated bioinformatics and machine learning
Amino acid sensors as key regulators of tumor biology
βIII-tubulin in malignant tumors: unveiling its biological functions, mechanisms and roles in drug resistance
Targeting purine metabolism as the next generation of cancer therapeutic strategies
The respiratory microbiota in lung cancer: bridging dysbiosis, immunomodulatory networks, and therapeutic opportunities
The role of TP53 mutations in oral cancer: molecular mechanisms and prognostic implications
Metabolic reprogramming of immune cells and metabolic intervention in cutaneous tumors
Malignancies of ISCs and their niche emerge as frontiers in precision therapy for colorectal cancer
Proteomics-driven precision oncology: from molecular profiling to biomarker discovery
Individual risk prediction and cancer prevention for the digital health era
Advanced Cancer Research: defining a platform for convergent oncology
Artificial intelligence in oncology drug discovery: from target identification to therapeutic molecule generation
Tumor microenvironment responsive nanotherapeutics in cancer treatment: obstacles, opportunities and future prospects
Post-translational modifications of KRAS: from molecular regulation to therapeutic targeting
EUVIMED